Anbesol Cold Sore Therapy Availability Update: What Patients Need to Know in 2026

If you've had trouble finding Anbesol Cold Sore Therapy on pharmacy shelves in 2026, you're not imagining it. Patients across the country continue to report that this over-the-counter cold sore ointment is frequently out of stock at their local pharmacies. Here's everything you need to know about its current availability and what it means for you.

Current Status: No Official National Shortage

As of 2026, the FDA has not issued a formal drug shortage designation for Anbesol Cold Sore Therapy. The FDA's Drug Shortages database primarily tracks prescription medications; OTC products like Anbesol are not included in this tracking system. Haleon US Services (the manufacturer, formerly part of GlaxoSmithKline Consumer Healthcare) continues to produce and distribute the product.

However, the absence of a formal shortage designation does not mean the product is easy to find. Patients report persistent localized stockouts at individual pharmacies — a pattern driven by the factors described below.

Why Patients Are Having Trouble Finding It

Several factors are contributing to ongoing availability gaps in 2026:

• Lean pharmacy inventory models: Post-pandemic, many pharmacies adopted tighter inventory management, reducing the number of units they stock for slower-moving OTC products. Anbesol Cold Sore Therapy, while popular, is a niche item that may be stocked in very small quantities.
• Seasonal demand surges: Cold sore outbreaks cluster around winter illness seasons, high-stress periods, and summer sun exposure — causing demand spikes that outpace pharmacy restock cycles.
• Distribution variability: Regional distributor inventory and delivery scheduling can mean that some areas replenish quickly while others wait longer for restocks.
• Benzocaine regulatory environment: Some retailers have reduced their benzocaine-containing product offerings in response to FDA warnings about methemoglobinemia risk, particularly for pediatric use. This has reduced the number of store locations that carry benzocaine-based products.

Historical Context: Has Anbesol Cold Sore Therapy Been Affected Before?

Anbesol Cold Sore Therapy has experienced periodic availability challenges since the COVID-19 pandemic disrupted retail OTC supply chains beginning in 2020. Supply chain normalization helped through 2021–2022, but localized stockout issues have persisted due to the ongoing shift toward lean inventory practices at major pharmacy chains.

The product has never been subject to an FDA recall or removal from market, and Haleon (the parent company) remains one of the world's largest consumer healthcare companies with robust manufacturing capacity. The availability issues patients experience are fundamentally a distribution and retail inventory issue, not a manufacturing one.

What the Future Looks Like

There is no indication that availability will worsen significantly. Anbesol Cold Sore Therapy remains in active production and distribution. However, given the lean-inventory retail environment, patients should expect that their specific pharmacy may not always have it on hand. The most reliable approach is to plan ahead: stock up when you find it, and use pharmacy inventory tools proactively rather than waiting until an outbreak forces an emergency search.

What to Do Right Now

If you're currently trying to find Anbesol Cold Sore Therapy, here are your best options:

1. Use medfinder: medfinder calls pharmacies near you to check which ones currently have it in stock, then texts you the results. Visit medfinder.com to get started.
2. Check online: CVS.com, Walgreens.com, and Walmart.com all allow you to check in-store availability by zip code. Amazon also carries the product with quick shipping options.
3. Consider alternatives: If Anbesol is unavailable locally, see our guide to alternatives to Anbesol Cold Sore Therapy for products that may be easier to find and offer similar relief.

The Bottom Line for Patients in 2026

Anbesol Cold Sore Therapy is not in an FDA-declared shortage, but localized stockouts are real and common. The product remains in active distribution by Haleon, and availability is generally adequate nationally. Your challenge is finding it at the specific pharmacy closest to you. With the right tools — like medfinder, online inventory checkers, and advance ordering — you can consistently have this product on hand when you need it most.